Martin Schlumpberger joined QIAGEN in Hilden, Germany in 2001. In his current position as Associate Director Sc. Appl. he is responsible for product development for Life Sciences applications in the areas of Exosomes and RNA isolation. Prior to working for QIAGEN, Martin worked as a post-doc at the Institute for Neurodegenerative Diseases at UCSF. He completed his Ph.D. in chemistry, with a strong focus on molecular biology and yeast genetics at the University of Stuttgart in 1996.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)